Lexaria Bioscience Corp. Cash And Cash Equivalents At Carrying Value

• Lexaria Bioscience Corp. showed a decrease of -46.8% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
• This data is from Lexaria Bioscience Corp.'s annual report (Form 10-K), filed with the SEC on November 28, 2022.
• XBRL data for this metric is available from 2009 to 2022 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 15 years of available data (2009 to 2022), Lexaria Bioscience Corp.'s Cash And Cash Equivalents At Carrying Value has grown by 1,660.7%.
• Historical annual values: Fiscal year 2022: $5.81 million | Fiscal year 2021: $10.92 million | Fiscal year 2020: $1.29 million | Fiscal year 2019: $1.29 million | Fiscal year 2018: $1.73 million | Fiscal year 2017: $2.53 million | Fiscal year 2016: $93.4 thousand | Fiscal year 2015: $260.1 thousand | Fiscal year 2014: $703.0 thousand | Fiscal year 2013: $65.5 thousand | Fiscal year 2013: $65.5 thousand | Fiscal year 2012: $180.5 thousand | Fiscal year 2011: $31.2 thousand | Fiscal year 2010: $63.0 thousand | Fiscal year 2009: $330.2 thousand.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026